Australia TGA Publishes New Guidance on the Management of GMP Compliance Signals

The guidance dated version 1.0 May 2021, outlines the Good Manufacturing Practice (GMP) compliance requirements for manufacturing biologicals and medicines …

read more...

Australia TGA Updates Regulatory Position for Data Collection Components Used by Software As a Medical Device

Rapid innovation in technology has driven significant changes to software function and adoption, giving rise to a larger number of devices …

read more...

Australia TGA Issues 3 Guidances on Transitional Arrangements and Obligations on Reclassification of Medical Devices in April 2021 

Reclassification of Active Medical Devices for Therapy with a Diagnostic Function. Version 1.0, April 2021: https://www.tga.gov.au/resource/reclassification-active-medical-devices-therapy-diagnostic-function   This guidance aims to assist sponsors …

read more...

China Issues New Pharmacovigilance Quality Management Practice/Standards

On 7th May 2021, China’s National Medical Products Administration issued a new Pharmacovigilance Quality Management Practice/Standards (ie. China GvP) to …

read more...

China NMPA Establishes Patent Linkage Registration Platform

On May 18, 2021, China’s Center for Drug Evaluation of National Medical Products Administration (NMPA) issued the “Notice on the public testing …

read more...

HSA Singapore Issues Updated Version of Regulatory Requirements For Clinical Trial New Applications And Subsequent Submissions

The new version Rev. No. 004 , issued on 28 April 2021, clarified on regulatory requirements for clinical trials of controlled drugs or psychotropic substances.   …

read more...

Singapore HSA Extends the Dossier Clarification Supplement For Biologics

HSA introduced the Dossier Clarification Supplement in April 2018 for chemical NDA and GDA to facilitate applicants to leverage the …

read more...

Singapore HSA Finalises Guidance On Electronic Labelling Of Therapeutic Products

HSA, in consultation with industry stakeholders, launched an e-labelling pilot trial for therapeutic products (TP) in August 2019.  The objective …

read more...

Thai FDA Announces Extension of Validity Of GMP Clearance Approvals

On 18 February 2021, Thai FDA announced that any GMP clearance approval letter which was approved before the date of …

read more...